Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 12, 1980 - Issue sup25
Submit an article Journal homepage
12
Views
0
CrossRef citations to date
0
Altmetric
Miscellany

Nordic Cefamandole Symposium: A Symposium of Eli Lilly Copenhagen, Denmark, November 15–16, 1979

Brian Gennery
Pages 1-121 | Published online: 02 Jan 2015

References

  • Barber, M.: Coagulase-positive staphylococci resistant to penicillin. J Pathol Bact 59: 373, 1947
  • Chain, E. B.: Penicillinase-resistant penicillins and the problem of penicillin-resistant staphylococci. In: Resistance of bacteria to the penicillins, CIBA Foundation Study Group No. 13, p. 3 (ed. A. V. S. De Rueck and M. P. Cameron). J. & A. Churchill, Ltd., London 1962
  • Datta, N. & Kontamichalou, P.: Penicillinase synthesis controlled by infectious R-factors in the Enterobacteriaceae. Nature 208:239, 1965
  • Garrod, L. P., Lambert, H. P. & O'Grady, F.: Antibiotic and chemotherapy, 4th ed. E. & S. Livingstone, Edinburgh & London 1973
  • Jack, G. W. & Richmond, M. H.: A comparative study of eight distinct β-lactamases synthesised by Gram-negative bacteria. J Gen Microbiol 61:43, 1970
  • Matthew, M., Harris, A., Marshall, M. & Ross, G. W.: The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 88: 169, 1975
  • Medeiros, A. A. & O'Brien, T. F.: Ampicillin-resistant Haemophilus influenzae type b possessing a TEM-like β-lactamase but little permeability barrier to ampicillin. Lancet i: 716, 1975
  • Kaiser, G. V., Gorman, M. & Webber, J. A.: Cefamandole-a review of chemistry and microbiology. J Infect Dis 137 ( Suppl.) S10–S16, 1978
  • Munch-Petersen, E. & Boundy, C.: Yearly incidence of penicillin resistant staphylococci in man since 1942. Bull Wrld Hlth Org 26:241, 1962
  • Onishi, H. R., Daoust, D. R., Zimmerman, S. B., Hendlin, D. & Stapley, E. O.: Cefoxotin: A semisynthetic cephamycin antibiotic. Resistance to β-lactamase inactivation. Antimicrob Agents Chemother 5: 38, 1974
  • Otten, H., Plempel, M. & Siegenthaler, W.: Antibiotika Fibel: Antibiotika-mikrobieller Infektionen, 4th ed., p. 205. Georg Thieme Verlag, Stuttgart 1975
  • Phillips, I.: Beta-lactamase-producing penicillin resistant gonococcus. Lancet ii: 656, 1976
  • Richmond, M. H.: Wild-type variants of exo-penicillinase from Staphylococcus aureus. Biochem J 94: 584, 1965
  • Richmond, M. H. β-Lactamases and Gram-negative bacteria. In: Cephalosporins, dimensions and future, p. 63 (ed. B. Edselius). Excerpta Medica, Amsterdam 1974
  • Richmond, M. H.: β-Lactam antibiotics and β-lactamases: Two sides of a continuing story. Rev Inf Dis 1:30, 1979
  • Richmond, M. H. & Sykes, R. B.: The β-lactamases of Gram-negative bacteria and their possible physiological role. Adv Microbiol Physiol 9: 31, 1973
  • Richmond, M. H. & Curtis, N. A. C.: The interplay of β-lactamases and intrinsic factors in the resistance of Gram-negative bacteria to penicillins and cephalosporins. Ann NY Acad Sci 235:553, 1974
  • Richmond, M. H. & Wotton, S.: Comparative study of seven cephalosporins: Susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli. Antimicrob Agents Chemother 10: 219, 1976
  • Rolinson, G. R., Stevens, S., Batchelor, F. R., Cameron-Wood, J. & Chain, E. B.: Bacteriological studies on a new penicillin-BR1241. Lancet ii: 564, 1960
  • Rolinson, G. N. & Sutherland, R. Semisynthetic penicillins. Adv Pharmacol Chemother 11: 151, 1973
  • Sykes, R. B. & Matthew, M.: The β-lactamases of Gram-negative bacteria and their role in resistance to β-lactam antibiotics. J Antimicrob Chemother 2: 115, 1976
  • Turner, J. R., Preston, D. A. & Wold, J. S.: Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate. Antimicrob Agents Chemother 12:67, 1977
  • Williams, J. D.: Changing antibiotic susceptibility of common bacteria. Practitioner 17:102, 1977

References

  • Wick, W. E. & Preston, D. A.: Biological properties of three-heterocyclic thiomethyl cephalosporin antibiotics. Antimicrob Agents Chemother 1:221–234, 1972
  • Eykyn, S., Jenkins, C. & King, A.: Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalolothin, and cephalexin. Antimicrob Agents Chemother 3: 657–661, 1973
  • Neu, H. C.: Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 6:177–182, 1974
  • Meyers, B. R., Leng, B. & Hirschman, S. Z.: Cefamandole: Antimicrobial activity in vitro of a new cephalosporin. Antimicrob Agents Chemother 8: 737–741, 1975
  • Hirschman, S. Z., Meyers, B. R. & Miller, A.: Antimicrobial activity of cefamandole against Salmonella typhi. Antimicrob Agents Chemother 11:369–371, 1977
  • Bran, J. L., Levison, M. E. & Kaye, D.: Survey for methicillin-resistant staphylococci. Antimicrob Agents Chemother 1:235–236, 1972
  • Bauer, A. W., Kirby, W. M. M., Sherris, J. C. & Turck, M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 6:493–696, 1966
  • Syriopoulou, V. Ph., Scheifele, D. W., Sack, C. M. & Smith, A. L.: Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother 16:51–513, 1979
  • Yourassowsky, E., Van Der Linden, M. P. & Lismont, M. J.: Growth curves, microscopic morphology, and subcultures of beta-lactamase-positive and -negative Haemophilus influenzae under the influence of ampicillin and cefamandole. Antimicrob Agents Chemother 15: 325–331, 1979
  • Olarte, J. & Galindo, E.: Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: Strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother 44:597–601, 1973
  • Meyers, B. R., Ribner, B., Yancovitz, S. & Hirschman, S. Z.: Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother 9: 140–144, 1973
  • Klebin, J. O., Tickhoff, T. C., Tilles, J. G. & Finland, M.: Cephalothin: Activity in vitro, absorption and excretion in normal subjects and clinical observations in 40 patients. Am J Med Sci 24:52–68, 1964
  • Klimek, J. J., Marsik, F. J., Bartlett, R. C., Weir, B., Shea, P. & Quintiliani, R.: Clinical, epidemiologic and bacteriologic observations for an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. Am J Med 61: 340–345, 1976

References

  • Bergström, S. & Normark, S.: β-Lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC mediated chromosomal β-lactamase. Antimicrob Agents Chemother. 16:427, 1979
  • Boman, H. G., Nordström, K. & Normark, S.: Penicillin resistance in Escherichia coli K 12: Synergism between penicillinases and a barrier in the outer part of the envelope. Ann NY Acad Sci 235:569, 1979
  • Burman, L. G., Park, J. T., Lindström, E. B. & Boman, H. G.: Resistance of Escherichia coli to penicillins. X. Identification of the structural gene for the chromosomal penicillinase. J Bacteriol 116: 123, 1973
  • Edlund, T., Grundström, T. & Normark, S.: Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K 12. Molec Gen Genet 173:115, 1979
  • Fu, K. P. & Neu, H. C.: Beta-lactamase stability of HR756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob Agents Chemother 14: 322, 1978
  • Jack, G. W. & Richmond, M. H.: A comparative study of eight distinct β-lactamases synthesized by Gram-negative bacteria. J Gen Microbiol 61:43, 1970
  • Jaurin, B. & Normark, S.: In vivo regulation of chromosomal β-lactamase in E. coli. J Bacteriol 138: 896, 1979
  • Lindström, E. B., Boman, H. G. & Steele, B. B.: Resistance of Escherichia coli to penicillins. VI. Purification and characterization of the chromosomally mediated penicillinase present in ampA-containing strains. J Bacteriol 101:218, 1970
  • Lindström, E. B. & Nordström, K.: Automated method for determination of penicillins, cephalosporins, and penicillinases. Antimicrob Agents Chemother 1:100, 1972
  • Matthew, M. & Hedges, R. W.: Analytical isoelectric focusing of R factor-determined β-lactamases: Correlation with plasmid compatibility. J Bacteriol 132: 341, 1976
  • Neu, H. C. & Fu, K. P.: Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of Gram positive and negative activity. Antimicrob Agents Chemother 13:657, 1978
  • Normark, S. & Burman, L. G.: Resistance of Escherichia coli to penicillins: Fine structure mapping and dominance of chromosomal beta-lactamase mutations. J Bacteriol 132:1, 1977
  • Normark, S., Edlund, T., Grundström, T., Bergström, S. & Wolf-Watz, H.: Escherichia coli K 12 mutants hyper-producing chromosomal β-lactamase by gene repetitions. J Bacteriol 132:912, 1977
  • Spratt, B. G.: Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K 12. Proc Nat Acad Sci 72: 2999, 1975
  • Sykes, R. B. & Matthew, M.: The β-lactamases of Gram-negative bacteria and their role in resistance to β-lactam antibiotics. J Antimicrob Chemother 2: 115, 1976
  • Yamagishi, S., O'Hara, K., Sawai, T. & Mitsuhashi, S.: The purification and properties of penicillin β-lactamases mediated by transmissible R-factors in Escherichia coli. J Biochem 66: 11, 1969

References

  • Moellering, R. C., Jr: Cefamandole-a new member of the cephalosporin family. J Infect Dis 137, Suppl. S52, 1978
  • Stone, H. H., Guest, B. S., Geheber, C. E. & Kolb, L. D.: Cefamandole in treatment of peritonitis. J Infect Dis 137, Suppl. S103, 1978
  • Levine, L. R., Russell, D. G. & McCain, E.: Cefamandole in the treatment of anaerobic infections. Contemp Surg 13:33, 1978
  • Levine, L. R. & McCain, E.: Clinical experience with cefamandole for treatment of serious bone and joint infections. J Infect Dis 137, Suppl. S119, 1978
  • Sanderson, P. J., Wren, M. W. D. & Baldwin, A. W. F.: Anaerobic organisms in post-operative wounds. J Clin Pathol 32: 143, 1979
  • Leigh, D. A., Simmons, K. & Edelgard, N.: Bacterial flora of the appendix fossa in appendicitis and post-operative wound infection. J Clin Pathol 27:997, 1974
  • Report by a Study Group: Metronidazole in the prevention and treatment of Bacteroides infections in gynaecological patients. Lancet ii: 1540, 1974
  • Meyers, B. & Hirschman, S. Z.: Antibacterial activity of cefamandole in vitro. J Infect Dis 137, Suppl. S25, 1978
  • Neu, H. C.: Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 6: 177, 1974
  • Eykyn, S., Jenkins, C., King, A. & Phillips, I.: Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin and cephalexin. Antimicrob Agents Chemother 3:657, 1973
  • Bodey, G. P. & Weaver, S.: In vitro studies of cefamandole. Antimicrob Agents Chemother 9:452, 1976
  • Ernst, E. C., Berger, S., Barza, M., Jacobus, N. V. & Tally, F. P.: Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 9:852, 1976
  • Eykyn, S., Jenkins, C., King, A. & Phillips, I.: Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin and cefamandole. Antimicrob Agents Chemother 9:690, 1976
  • Sutter, V. L. & Finegold, S. M.: Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother 10:736, 1976
  • Kaiser, G. V., Gorman, M. & Webber, J. A.: Cefamandole-a review of chemistry and microbiology. J Infect Dis 137, Suppl. S10, 1978
  • Grose, W. F., Bodey, G. P. & Stewart, D.: Observations in man on some pharmacologic features of cefamandole. Clin Pharmacol Ther 20:579, 1976
  • Fong, I. W., Ralpa, E. D., Engelking, E. R. & Kirby, W. M. M.: Clinical pharmacology of cefamandole as compared with cephalothin. Antimicrob Agents Chemother 9: 65, 1976
  • Griffith, R. S., Black, H. R., Brier, G. L. & Wolny, J. D.: Cefamandole: In vitro and clinical pharmacokinetics. Antimicrob Agents Chemother 10:814, 1976
  • Walker, S. H. & Gahol, V. P.: Pharmacokinetics of cefamandole in infants and children. Current Chemotherapy (Proceedings of the 10th International Congress of Chemotherapy), 11, 791, 1978. American Society for Microbiology

References

  • Neu, H. C.: Cefamandole, a cephalosporin with an unusually wide spectrum of activity. Antimicrob Agents Chemother 6: 177–182, 1974
  • Wold, J. S., Joost, R. R., Black, H. R. & Griffith, R. S.: Hydrolysis of cefamandole nafate to cefamandole in vivo. J Infect Dis 137 ( S): 17–24, 1978
  • Neu, H. C.: Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis 137 ( S): 80–87, 1978
  • Fong, I. W., Ralph, E. D., Engelking, E. R. & Kirby, W. M.: Clinical pharmacology of cefamandole compared with cephalothin. Antimicrob AgentsChemother 9:65–69, 1976
  • Griffith, R. S., Black, H. R., Brier, G. L. & Wolny, J. D.: Cefamandole: In vitro and clinical pharmacokinetics. Antimicrob Agents Chemother 10:814–823, 1976
  • Barza, M., Melethil, S., Berger, S. & Ernest, E. C.: Comparative pharmacokinetics of cefamandole, cephapirin and cephalothin in healthy subjects and effect of repeated dosing. Antimicrob Agents Chemother 10:421–425, 1976
  • Meyers, B. R., Ribner, B., Yancovitz, E. & Hirschman, S. Z.: Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother 9:140–144, 1976
  • Shemonsky, N. K., Carrizosa, J. & Levison, M. E.: In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalosporin antibiotic. Antimicrob Agents Chemother 8:679–683, 1975
  • Mellin, H. E., Welling, P. G. & Madsen, P. O.: Pharmacokinetics of cefamandole in patients with normal and impaired renal function. Antimicrob Agents Chemother 11:262–266, 1977
  • Regamey, C. & Vonlanthen, M.: Pharmacokinetics of cefamandole and cephalothin after intravenous administration in healthy adult volunteers and in vitro antibacterial spectrum. In: Current chemotherapy, vol. 1 (ed. W. Sigenthaler and R. Luthy), pp. 793–795, 1978
  • Aziz, N. S., Gambertoglio, J. G., Lin, E. T., Grausz, H. & Benet, L. Z.: Pharmacokinetics of cefamandole using a HPLC assay. J Pharm Biopharm 6:153–164, 1978
  • Naber, K. G. & Zinati, A. H.: Pharmacokinetic studies and therapeutic evaluation of cefamandole in urology. In: Current chemotherapy, vol. 1 (ed W. Siegenthaler and R. Luthy), pp. 801–803, 1978
  • Grose, W. E., Bodey, G. P. & Stewart, D.: Observations in man on some pharmacologic features of cefamandole. Clin Pharmacol Ther 20:579–584, 1976
  • Walker, S. H. & Gahol, V. P.: Pharmacodynamics of cefamandole in infants and children. Antimicrob Agents Chemother 14:315–317, 1978
  • Rodriguez, W. J., Ross, J., Khan, W. N. & Goldenberg, R.: Clinical and laboratory evaluation of cefamandole in infants and children. J Infect Dis 137 ( S): 150–154, 1978
  • Azimi, P. H.: Clinical and laboratory investigation of cefamandole therapy in infections in infants and children. J Infect Dis 137 ( S): 155–160, 1978
  • Agbayani, M. M., Khan, A. J., Kemawikasit, P., Rosenfeld, W., Salazar, D., Kumar, K., Glass, L. & Evans, H. E.: Pharmacokinetics and safety of cefamandole in newborn infants. Antimicrob Agents Chemother 15:674–676, 1979
  • Brogard, J. M., Conte, F. & Pinget, M.: Pharmacokinetics of cephalosporin antibiotics. Antibiot Chemother 25: 123–162, 1978
  • Quinn, E. L., Madhavan, T., Wilson, R., Guise, E., Levin, N., Block, M., Burah, K., Fisher, E., Suarez, A. & Del Busto, R.: Cefamandole observations on its spectrum, concentration in bone, bile, excretion in renal failure and clinical efficacy. In: Current chemotherapy, vol. 1 (ed. W. Siegenthaler and R. Luthy), pp. 803–804, 1978
  • Ratzan, K. R., Baker, H. B. & Lauredo, I.: Excretion of cefamandole, cefazolin and cephalothin into T-tube bile. Antimicrob Agents Chemother 13:985–987, 1978
  • Tschirkov, T., Eigel, P., Satter, P. & Knothe, H.: Cefamandole and cephalothin in open-heart surgery: Comparative pharmacokinetic appraisal. In: Current chemotherapy, vol. 1 (ed. W. Siegenthaler and R. Luthy), pp. 821–822, 1978
  • Waterman, N. G., Eikenberg, H. V. Scharfenberger, L.: Concentrations of cefamandole in serum, interstitial fluid, bile and urine. Antimicrob Agents Chemother 10:733–735, 1976
  • Axelrod, J. L. & Kochman, R. S.: Cefamandole concentrations in human aqueous humor. In: Current chemotherapy, vol. 1 (ed. W. Siegenthaler and R. Luthy), pp. 799–801, 1978
  • Korzeniowski, O. M., Carvalho, E. M., Jr, Rocha, H. & Sande, M. A.: Evaluation of cefamandole therapy of patients with bacterial meningitis. J Infect Dis 137 ( S): 169–179, 1978
  • Steinberg, E. A., Overturf, G. D., Wilkins, J., Baraff, L. J., Streng, J. M. & Leedom, J. M.: Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae, type B. J Infect Dis 137 ( S): 180–186, 1978
  • Sullivan, H. R., Due, S. L., Kau, D. L. K., Quay, J. F. & Miller, W. M.: Metabolic fate of [14C] cefamandole, a parenteral cephalosporin antibiotic in rats and dogs. Antimicrob Agents Chemother 12:73–79, 1977
  • Griffith, R. S., Black, H. R., Brier, G. L. & Wolny, J. D.: Effect of probenecid on the blood levels and urinary excretion of cefamandole. Antimicrob Agents Chemother 11:809–812, 1977
  • Parry, M. F., Goldberger, M. J. & Neu, H. C.: Therapy of serious infections with cefamandole. Infection 6:236–240, 1978
  • Nightingale, C. H., Greene, D. S. & Quintiliani, R.: Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci 64:1899–1927, 1975
  • Schrogie, J. J., Rogers, J. D., Yeh, K. C., Davies, R. U., Holmes, G. I., Skeggs, H. & Martin, C. M.: Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins. Rev Infect Dis 1:90–97, 1979
  • Regamey, C., Libke, R. D., Clarke, J. T. & Kirby, W. M. M.: Pharmacokinetics of parental sodium cephalexin in comparison with cephalothin and cefazolin. Infection 2:132–136, 1974
  • Kirby, W. M. M. & Regamey, C.: Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis 128 ( S): 341-346, 1973

References

  • Boxer, G. E., Jelinek, V. C. & Edison, A. O. Streptomycin: Clearance and binding to protein. J Pharmacol Exp Ther 97:93–104, 1949
  • Boxer, G. E., Jelinek, V. C., Tempsett, R., Dubois, R. & Edison, A. O. Streptomycin in the blood: Chemical determinations after single and multiple intramuscular injections. J Pharmacol Exp Ther 92:226–235, 1948
  • Bryan, C. S. & Stone, W. J. Antimicrobial dosage in renal failure: A unifying monogram. Clin Nephrol 7:81–84, 1977
  • Dettli, L., Spring, P. & Habersang, R. Drug dosage in patients with impaired renal function. Post-grad Med J 46: 32–35, 1970
  • Griffith, R. S., Black, H. R., Brier, G. L. & Wolny, J. D. Cefamandole: in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother 10:814–823, 1976
  • Lilly Research Laboratories. Cefamandole nafate. Clinical Investigational Manual. Lilly Research Laboratories. Indianapolis, Ind.
  • Mellin, H.-E., Welling, P. G. & Madsen, P. O. Pharmacokinetics of cefamandole in patients with normal and impaired renal function. Antimicrob Agents Chemother 11:262–266, 1977
  • Meyers, B. R. & Hirschman, S. Z. Pharmacokinetics of cefamandole in patients with renal failure. Antimicrob Agents Chemother 11:248–250, 1977
  • Meyers, B. R., Ribner, B., Yancovitz, S. & Hirschman, S. Z. Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother 9: 140–144, 1976
  • Ratzan, K. R., Baker, H. B. & Lauredo, I. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile. Antimicrob Agents Chemother 13:985–987, 1978
  • Snedecor, G. W. & Cochran, W. G. 1967. Statistical methods, 6th ed., p. 272. Iowa State University Press, Ames

References

  • Barza, M., Sr, Srijumaran, M., Merger, S. & Ernst, E.: Comparative pharmokinetics of cefamandole, cephapirin and cephalothin in healthy subjects and effects of repeated dosing. Antimicrob Agents Chemother 10:421–426, 1976
  • Cuna, B. A., Gossling, H. R., Pasternak, H. S., Nightingale, C. H. & Quintiliani, R.: The penetration characteristics of cefazolin, cephalothin and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg 59 A: 856–859, 1977
  • Fitzergald, R. H., Jr, Kelly, P. J., Snyder, R. J. & Washington, J. A.: II. Penetration of methicillin, oxacillin, and cephalothin into bone and synovial tissues. Antimicrob Agents Chemother 14: 723–726, 1978
  • Kanyuck, D. O., Welles, J. S., Emmerson, J. L. & Anderson, R. C.: The penetration of cephalosporin antibiotics into bone (35414). Proc Soc Exp Biol Med 136:997–999, 1971
  • Nelson, C. L., Bergfeld, J. A., Schwartz, J. & Kolczun, M.: Antibiotics in human hematoma and wound fluid. Clin Orthop Relat Res 108: 138–144, 1975
  • Patel, D., Mollering, R. C., Thrasher, K., Fahmy, N. R. & Harris, W. H.: The effect of hypotensive anesthesia on cephalothin concentrations in bone and muscle of patients undergoing total hip replacement. J Bone Joint Surg 61 A:531–538, 1979
  • Pollard, J. P., Hughes, S. P. F., Scott, J. E., Evans, M. J. & Benson, M. K. D'A.: Prophylactic antibiotics following total hip replacement. A controlled trial. J. Bone Joint Surg 61B: 118, 1979
  • Schurman, D. J., Johnson, B. L., Jr & Amstutz, H. C.: Staphylococcus aureus and Micrococcus species: Knee joint infections: A study of the influence of antibiotics, metal debris, blood and steroids in a rabbit model. J Bone Joint Surg 57 A: 40–49, 1975
  • Schurman, D. J., Burton, D. A., Kajiyama, G., Moser, K. & Nagel, D.: Sodium cephapirin deposition into human bone. Curr Therap Res 20: 194–203, 1976
  • Schurman, D. J., Hirshman, H. P., Kajiyama, G., Moser, K. & Burton, D. A.: Cefazolin concentration in bone and synovial fluid. J Bone Joint Surg 60: 359–362, 1978
  • Smilack, J. D., Flittie, W. H. & Williams, T. W., Jr: Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agent Chemother 9: 169-171, 1976

References

  • Bodey, G. P. & Weaver, S.: In vitro studies of cefamandole. Antimicrob Agents Chemother 9:452–547, 1976
  • Griffith, R. S., Black, H. R., Brier, G. L. & Wolny, J. D.: Cefamandole: In vitro and clinical pharmacokinetics. Antimicrob Agents Chemother 10 (5): 814–823, 1976
  • Jones, R. N. & Fuchs, P. C.: Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8000 clinical bacterial isolates. Antimicrob Agents Chemother 9 (6): 1066–1069, 1976
  • The Medical Letter: Cefamandole and cefoxitin (ed. M. Abramowicz), 21 (3): 13–15. The Medical Letter Inc., New Rochelle, N.Y. 1979
  • Ratzan, K. R., Ruiz, C. & Irvin, G. L.: Biliary tract excretion of cefazolin, cephalothin and cephaloridine in the presence of biliary tract disease. Antimicrob Agents Chemother 6 (4): 426–431, 1974
  • Ratzan, K. R., Baker, H. B. & Lauredo, I.: Excretion of cefamandole, cefazolin and cephalothin into T-tube bile. Antimicrob Agents Chemother 13 (6): 985–987, 1978
  • Sales, J. E., Sutcliffe, M. & O'Grady, F.: Cephalexin levels in human bile in presence of biliary tract disease. Brit Med J 3:441–442, 1972

References

  • Neu, H. C.: Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 6: 177, 1974
  • Ratzan, K. R., Baker, B. H. & Lauredo, I.: Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile. Antimicrob Agents Chemother i: 985, 1978
  • Stone, H. H., Hooper, C. A., Kolb, L., Geheber, C. & Dawkins, E. J.: Antibiotic prophylaxis in gastric, biliary, and colonic surgery. Ann Surg 184:443, 1976
  • Strachan, C. J. L., Black, J., Powis, S. J. A., Waterworth, T. A., Wise, R., Wilkinson, A. R., Burdon, D. W., Severn, M., Mitra, B. & Norcott, H.: Prophylactic use of cephazoline against wound sepsis after cholecystectomy. Br Med J i: 1254, 1977

References

  • Bach, V. T., Roy, I. & Thadepalli, H.: Susceptibility of anaerobic bacteria to cefoxitin and related compounds. Antimicrob Agents Chemother 11:912, 1977
  • Bartlett, J. G. & Gorbach, S. L.: Pseudomembranous enterocolitis. (Antibiotic related colitis.) In: Advances in internal medicine, p. 455 (ed. G. H. Stollerman). Year Book Medical Publishers, Chicago 1977
  • Barza, M., Samuelson, T. & Weinstein, L.: Penetration of antibiotics into fibrin loci in vivo. II. Comparison of nine antibiotics: Effect of dose and degree of protein binding. J Infect Dis 129:66, 1974
  • Bergeron, M. G.: A review of models for the therapy of experimental infections. Scand J Infect Dis, Suppl. 14: 189, 1978
  • Bergeron, M. G., Nguyen, B. M. & Gauvreau, L.: Influence of constant infusion versus bolus injections of antibiotics on in vivo synergy. Infection, Suppl. 1:38, 1978
  • Bergeron, M. G., Nguyen, B. M., Trottier, S. & Gauvreau, L.: Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots. Antimicrob Agents Chemother 12: 682, 1977
  • Birnbaum, J., Stapley, E. O., Miller, A. K., Wallick, H., Hendlin, D. & Woodruff, H. B.: Cefoxitin, a semi-synthetic cephamycin: A microbiological overview. J Antimicrob Chemother 4, Suppl. B: 15, 1978
  • Brown, D. M.: Tissue distribution of penicillins. Post-grad Med J 40, Suppl. 31, 1964
  • Busch, D. F., Heseltine, P. N. R., Meyer, R. D., Sutter, V. L. & Finegold, S. M.: Cefoxitin sodium therapy of anaerobic infections. J Antimicrob Chemother 4, Suppl. B: 197, 1978
  • Carbon, C., Contrepois, A., Brion, N. & Lamotte-Barrillon, S.: Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits. Antimicrob Agents Chemother 11:594, 1977
  • Chow, A. W. & Bednorz, D.: Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. Antimicrob Agents Chemother 14:668, 1978
  • Daikos, G. K. & Weinstein, L.: Mikrobielle Persistenz studiert in vivo durch Anwendung künstlicher Fibringerinnsel 38:521, 1960
  • Darland, G. & Birnbaum, J.: Cefoxitin resistance to beta-lactamase: A major factor for susceptibility of Bacteroides fragilis to the antibiotic. Antimicrob Agents Chemother 11:725, 1977
  • Dubois, J. & Pechère, J. C.: Activity of ten antimicrobial agents against anaerobic bacteria. J Antimicrob Chemother 4: 329, 1978
  • Gardner, W. G., Prior, R. B. & Perkins, R. L.: Fluid and pharmacological dynamics in a subcutaneous chamber implanted in rats. Antimicrob Agents Chemother 4: 196, 1973
  • Geddes, A. M. & Wilcox, R. M. L.: Cefoxitin in abdominal sepsis. J Antimicrob Chemother 4, Suppl. B: 151, 1978
  • Gerding, D. N., Kromhout, J. P., Sullivan, J. J. & Hall, W. H.: Antibiotic penetrance of ascitic fluid in dogs. Antimicrob Agents Chemother 10:850, 1976
  • Gerding, D. N., Wendell, H. H., Schierl, E. A. & Manion, R. E.: Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits. Antimicrob Agents Chemother 902, 1976
  • Henderson, D. K., Chow, A. W. & Guze, L. B.: Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents. Antimicrob Agents Chemother 11:679, 1977
  • Jahre, J. A., Neu, H. C., Parry, M. F. & Goldberger, M. J.: Cefoxitin sodium and cephalothin in the treatment of serious infections. J Antimicrob Chemother 4, Suppl. B: 105, 1978
  • Kaye, D., Parsons, J. N., Carrizosa, J. & Kobasa, W. D.: Treatment of experimental Staphylococcus aureus abscesses: Comparison of cefazolin, cefoxitin, and cefamandole. Antimicrob Agents Chemother 15: 200, 1979
  • Mohan, K., Gordon, R. C., Beaman, T. C., Belding, R. C., Luecke, D., Edmiston, C. & Gerhardt, P.: Synergism of penicillin and gentamicin against Listeria monocytogenes in ex vivo hemodialysis culture. J Infect Dis 135:51, 1977
  • Neu, H. C., Aswapokee, N., Aswapokee, P. & Fu, K. P.: HR 756, a new cephalosporin active against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother 15:273, 1979
  • Norrby, R., Brorsson, J. E. & Seeberg, S.: Comparative study of the in vitro antibacterial activity of cefoxitin, cefuroxime, and cephaloridine. Antimicrob Agents Chemother 9:506, 1976
  • O'Keefe, J. P., Tally, F. P., Barza, M. & Gorbach, S. L.: Inactivation of penicillin G during experimental infection with Bacteroides fragilis. J Infect Dis 137: 437, 1978
  • Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis. Rev Infect Dis 1: 106, 1979
  • Speranza, V. & Mennini, G.: Clinical experience with cefoxitin sodium in abdominal surgery. J Antimicrob Chemother 4, Suppl. B: 143, 1978
  • Stone, H. H., Guest, B. S., Geleber, C. E. & Kolh, L. D.: Cefamandole in the treatment of peritonites. J Infect Dis 137: 103, 1978
  • Sutter, V. L. & Finegold, S. M.: Susceptibility of anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis 131:417, 1975
  • Tally, F. P., Jacobus, N. V., Bartlett, J. G. & Gorbach, S. L.: Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother 7: 128, 1975
  • Tan, J. S. & Salstrom, S. J.: Levels of carbenicillin, ticarcillin, cephalothin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid. Antimicrob Agents Chemother 11:698, 1977
  • Thadepalli, H., Webb, D., Roy, I. & Bach, V.: Evaluation of cefoxitin sodium therapy in anaerobic infections. J Antimicrob Chemother 4, Suppl. B: 203, 1978
  • Ton, J. S., Trott, A., Phair, J. P. & Watanakunakorn, C.: A method for measurement of antibiotics in human interstitial fluid. J Infect Dis 126:492, 1972
  • Waterman, N. G., Eickenberg, H. U. & Scharfenberger, L.: Concentration of cefamandole in serum interstitial fluid, bile, and urine. Antimicrob Agents Chemother 10:733, 1976
  • Waterman, N. G. & Kaston, L. B.: Interstitial fluid and serum antibiotic concentrations. Arch Surg 105: 192, 1972
  • Waterman, N. G., Raff, M. J., Scharfenberger, L. & Barnwell, P. A.: Protein binding and concentrations of cephaloridine and cefazolin in serum, and interstitial fluid of dogs. J Infect Dis 133:642, 1976
  • Wilson, P., Leung, T. & Williams, J. D.: Antibacterial activity, pharmacokinetics, and efficacy of cefoxitin in patients with abdominal sepsis and other infections. J Antimicrob Chemother 4, Suppl. B: 127, 1978

References

  • Kaiser, G. V., Gorman, M. & Webber, J. A.: Cefamandole-a review of chemistry and microbiology. J Infect Dis 137 ( Suppl.): S10, 1978
  • Neu, H. C.: Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 6:177, 1974
  • Ernst, E. C., Berger, S., Barza, M. : Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 9: 852, 1976
  • Eickoff, T. C. & Ehret, J. M.: In vitro comparison of cefoxitin, cefamandole, cephalexin and cephalothin. Antimicrob Agents Chemother 9:994, 1976
  • Data on file. Lilly Research Laboratories
  • Richmond, M. H. & Wotton, S.: Comparative study of seven cephalosporins: Susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli. Antimicrob Agents Chemother 10:219, 1976
  • Neu, H. C. & Fu, K. P.: A comparative study of the acitivity of cefamandole and other cephalosporins and analysis of the B-lactamase stability and synergy of cefamandole with aminoglycosides. J Infect Dis 137 ( Suppl.): S38, 1978
  • Kattan, S., Cavanaugh, P. & Williams, J. D.: Relationship between B-lactamase production by Haemophilus influenzae and sensitivities to penicillins and cephalosporins. J Antimicrob Chemother 1: 79, 1975
  • Kammer, R. B., Preston, D. A., Turner, J. R. & Hawley, L. C.: Rapid detection of ampicillin resistant Hemophilus influenzae and their susceptibility to sixteen antibiotics. Antimicrob Agents Chemother 8:91, 1975
  • Wick, W. E.: In vitro and in vivo laboratory comparison of cephalothin and desacetylcephalothin. Antimicrob Agents Chemother 1965:870, 1966
  • Griffith, R. S., Black, H. R., Brier, G. L. & Wolny, J. D.: Cefamandole in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother 10: 814, 1976
  • Holdeman, L. V.: Anaerobe Laboratory Manual, 2nd ed. V. P. I. Anaerobe Laboratory, 1972
  • Bauer, A. W., Kirby, W. M. M., Sherris, J. C. & Turck, M.: Antibiotic susceptibility testing by a standardized single method. Am J Clin Pathol 45:493, 1966
  • Gorback, S. L. & Bartlett, J. C.: Anaerobic infections. New Engl J Med 290: 1177, 1974
  • Stone, H. H., Kolb, L. D. & Geheber, C. E.: Incidence and significance of intraperitoneal anaerobic bacteria. Ann Surg 181:705, 1975
  • Moellering, R. C., Jr: Cefamandole-a new member to the cephalosporin family. J Infect Dis 137 ( Suppl.): S2, 1978
  • Findell, C. M. & Sherris, J. C.: Susceptibility of enterobacter to cefamandole: Evidence for a high mutation rate to resistance. Antimicrob Agents Chemother 9:970, 1976
  • Perkins, R. L., Fass, R. J., Warner, J. F. : Cefamandole nafate therapy of respiratory tract, skin and soft tissue infections in 74 patients. J Infect Dis 137 ( Suppl.): S110, 1978
  • Minor, M. R., Sande, M. A., Dilworth, J. A. & Mandell, G. L.: Cefamandole treatment of pulmonary infection caused by gram-negative rods. J Antimicrob Chemother 2:49, 1976
  • Short, H. D., Gentry, L. & Sessoms, S.: Cefamandole nafate therapy in the treatment of acute urinary tract infections. J Antimicrob Chemother 2: 345, 1976

References

  • Ledger, W. J.: Infections in obstetrics and gynecology: New developments in treatment. Surg Clin North Am 52: 1447, 1972
  • Thadepalli, H., Gorbach, S. & Keith, L.: Anaerobic infections of the female genital tract: Bacteriologic and therapeutic aspects. Am J Obstet Gynecol 117:1034, 1973
  • Swenson, R. M., Michaelson, T. C., Daly, M. J. & Spaulding, E. H.: Anaerobic bacterial infections of the female genital tract. Obstet Gynecol 42:538, 1973
  • Sweet, R. L. & Ledger, W. J.: Puerperal infectious morbidity: A two-year review. Am J Obstet Gynecol 117:1093, 1973
  • Gorbach, S. L. & Barlett, J. G.: Anaerobic infections. N Engl J Med 290:1177, 1974
  • Chow, A. W., Marshall, J. R., & Guze, L. B.: Anaerobic infections of the female genital tract: Prospects and perspectives. Obstet Gynecol Surv 30:477, 1975
  • Cunningham, F. G., Hauth, J. C., Strong, J. D., : Evaluation of tetracycline or penicillin-ampicillin for treatment of acute pelvic inflammatory disease. N Engl J Med 296: 1380, 1977
  • Meny, R., Webb, C. D. & Fiedelman, W.: Carbenicillin therapy of anaerobic infections. Curr Ther Res 17:478, 1975
  • Thadepalli, H.: Treatment of anaerobic infections with carbenicillin. Curr Ther Res 20:589, 1976
  • Cunningham, F. G., Gilstrap, L. G. & Kappus, S. S.: Treatment of obstetric and gynecologic infections with cefamandole. Am J Obstet Gynecol 133:602–609, 1979
  • Gilstrap, L. C., Cunningham, F. G. & Kappus, S. S.: Cefamandole for treatment of infection following cesarean section. Contemp Obstet Gynecol (in press)
  • Sweet, R. L. & Ledger, W. J.: Cefoxitin: Single-agent treatment of mixed aerobic-anaerobic pelvic infections. Obstet Gynecol 54:193–198, 1979
  • Neu, H. C.: Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 6: 177, 1974
  • Staff of Anaerobe Laboratory: Anaerobe Laboratoy Manual, Blacksburg, Virginia, 1977, Virginia Polytechnic Institute
  • Buchanan, R. E. & Gibbons, N. E.: Bergey's manual of determinative bacteriology, ed. 8; Williams & Wilkins Co., Baltimore 1974
  • Sutter, V. L., Kwok, Y. Y. & Finegold, S. M.: Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. Appl Microbiol 23:268, 1972
  • Cunningham, F. G., Hauth, J. C., Strong, J. D., : Infectious morbidity following cesarean section: A comparison of two treatment regimens. Obstet Gynecol 52:656, 1978
  • Pritchard, J. A. & Whalley, P. J.: Abortion complicated by Clostridium perfringens infection. Am J Obstet Gynecol 111:484, 1971
  • Cunningham, F. G., Hauth, J. C., Gilstrap, L. C. : The bacterial pathogenesis of acute pelvic inflammatory disease. Obstet Gynecol 52:161, 1978
  • Sweet, R. L.: Anaerobic infections of the female genital tract. Am J Obstet Gynecol 122: 891, 1973
  • Gorbach, S. L.: Antibiotic therapy of obstetric and gynecologic infections. Surg Clin North Am 55: 1373, 1975
  • Schwarz, R. H. & Fruiterman, N. R.: Life-threatening infections in pregnancy. Clin Obstet Gynecol 19:561, 1976
  • Ledger, W. J.: Hospital acquired gynecologic infections. In: Infections in the female, Lea & Febiger, Philadelphia 1977, chap. 8, pp. 142–176.
  • Nastro, J. N. & Finegold, S. M.: Bactericidal activity of five antimicrobial agents. J Infect Dis 126: 104, 1972
  • Bodner, S. J., Koenig, G. & Goodman, J. S.: Bacteremic bacteroides infections. Ann Intern Med 73:537, 1970
  • Martin, W. J., Gardner, M. & Washington, J. A.: In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother 1:148, 1972
  • Monif, G. R. G. & Baer, H.: In vitro susceptibility of bacteroides strains to tetracycline, chloramphenicol, doxycycline, and clindamycin. Obstet Gynecol 43:211, 1974
  • Chow, A. W., Patten, V. & Guze, L. B.: Comparative susceptibility of anaerobic bacteria to minocycline, droxycycline and tetracycline. Antimicrob Agents Chemother 7:46, 1975
  • diZerega, G., Yonekura, L., Roys, Nakamura, R. M. & Ledger, W. J.: A comparison of clindamycin-gentamicin and penicillin-gentamicin in treatment of post-cesarean endomyomyometritis. Am J Obstet Gynecol 134:238–242, 1979
  • Stone, H. H., Guest, B. S., Geheber, C. E. & Kolb, L. D.: Cefamandole in treatment of peritonitis. J Infect Dis (Suppl). 137: S103, 1978
  • Fong, I. W., Ralph, E. D., Engelking, E. R. & Kirby, W. M. M.: Clinical pharmacology of cefamandole as compared with cephalothin. Antimicrob Agents Chemother 9:65, 1976
  • Meyers, B. R., Ribner, B., Yancovitz, S. & Hirschman, S. Z.: Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother 9:140, 1976
  • Neu, H. C.: Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis (Suppl) 137: S80, 1978

References

  • Bailey, G., Rosenbaum, J. M. & Anderson, B.: Toxic epidermal necrolysis. J Am Med Assoc 191:107–110, 1965
  • Bailey, W. R. & Scott, E. G. (ed.): Diagnostic microbiology, 3rd ed., p. 368. C. V. Mosby, St Louis. 1970
  • Bauer, A. W., Kirby, W. M. M., Sherris, J. C. & Turck, M.: Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 45: 493–496, 1966
  • Ericsson, H. M. & Sherris, J. C.: Antibiotic sensitivity testing: Report of an international collaborative study. Acta Pathol Microbiol Scand Sect B Suppl. 217:1–90, 1971
  • Ernst, E. C., Berger, S., Barza, M., Jacobus, N. V. & Tally, F. P.: Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 9: 852–855, 1976
  • Grose, W. E., Bodey, G. P. & Stewart, D.: Observations in man on some pharmacologic features of cefamandole. Clin Pharmacol Ther 20:579–584, 1976
  • Grove, D. & Randall, W. A.: Assay methods for antibiotics. In Antibiotic monograph no. 2. Medical Encyclopedia, Inc., New York, 1955
  • Holdeman, L. V. & Moore, W. E. C.: Anaerobe laboratory manual. Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, 1972
  • Jones, R. N. & Fuchs, P. C.: Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8000 clinical bacterial isolates. Antimicrob Agents Chemother 9:1066–1069, 1976
  • Kaiser, G. V., Gorman, M. & Webber, J. A.: Cefamandole-a review of chemistry and microbiology. J Infect Dis 137 ( Suppl.): S10–S16, 1978
  • Lennette, E. H., Spaulding, E. H. & Truant, J. P. (ed.).: Manual of clinical microbiology. American Society for Microbiology, Washington, D.C., 1974
  • Liu, C., Hinthorn, D. R., Hodges, G. R., Rosett, W., Gerjarusak, P., Dworzack, D. & Harms, J.: Clinical evaluations of the efficacy and safety of cefamandole nafate, p. 811–812. In W. Siegenthaler and R. Lüthy (ed.), Current chemotherapy: Proceedings of the 10th International Congress of Chemotherapy. American Society for Microbiology, Washington, D.C., 1978
  • Meyers, B. R. & Hirschman, S. Z.: Antibacterial activity of cefamandole in vitro. J Infect Dis 137 ( Suppl.): S25–S31, 1978
  • Neu, H. C.: Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis 137 ( Suppl.): S80–S87, 1978
  • Perkins, R. L., Fass, R. J., Warner, J. F. & Prior, R. B.: Cefamandole nafate evaluation in 74 patients, p. 815–817. In W. Siegenthaler and R. Lüthy (ed.), Current chemotherapy: Proceedings of the 10th International Congress of Chemotherapy. American Society for Microbiology, Washington, D.C., 1978
  • Starge, M. D., Thompson, F. S., Phillips, S. E., Lombard, G. L. & Dowell, V. R., Jr: Modification of the Minitek Miniaturized Differentiation System for characterization of anaerobic bacteria. J Clin Microbiol 3:291–301, 1976
  • Steers, E. E., Foltz, E. L. & Graves, B. S.: An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot Chemother 9:307–311, 1959
  • Stone, H. H., Guest, B. S., Geheber, C. E. & Kolb, L. D.: Cefamandole in treatment of peritonitis. J Infect Dis 137 ( Suppl.): S103–S109, 1978
  • Zak, F. G., Fellner, M. J. & Geller, A. J.: Toxic epidermal necrolysis (Lyell). Am J Med 37:140–146, 1964

References

  • Azimi, P. H.: Clinical and laboratory investigation of cefamandole in infections of infants and children. Antimicrob Agents Chemother 13:955, 1978
  • Azimi, P. H.: Clinical and laboratory investigation of cefamandole therapy of infections in infants and children. J Infect Dis 137, Suppl. 155, 1978
  • Cox, C. E.: Controlled trial of cefamandole and cefazolin in the treatment of urinary tract infections. In: Current chemotherapy, p. 817 (ed. W. Siegenthaler and R. Luthy). American Society for Microbiology, Washington, D.C. 1978
  • Cunningham, F. G., Gilstrap, L. C. & Kappas, S. S.: Treatment of obstetric and gynecologic infections with cefamandole. Am J Obstet Gynecol 133:602, 1979
  • Delgado, D. G., Brau, C. J., Cobbs, C. G. & Dismukes, W. E.: Clinical and laboratory evaluation of cefamandole in the therapy of haemophilus spp. bronchopulmonary infections. Antimicrob Agents Chemother 15:507, 1979
  • Dillon, M. L., Bowling, B. A. & Postlethwait, R. W.: Cephaloridine therapy in patients with surgical infections. Surg Gynecol Obstet 134:83, 1972
  • Eykyn, S., Jenkins, C., King, A. & Phillips, I.: Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother 3:657, 1973
  • Gentry, L. O.: Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections. J Infect Dis 137, Suppl. 144, 1978
  • Hoverman, I. V. & Gentry, L. O.: Cefamandole nafate in the treatment of acute bacterial pneumonia. Curr Ther Res 24:622, 1978
  • Hoyme, U. & Madsen, P. O.: Cefamandole and cefazolin in the therapy of complicated urinary tract infections. J Infect Dis 137, Suppl. 100, 1978
  • Kienitz, M.: Cephalosporin antibiotics in the treatment of acute osteomyelitis in children. Postgrad Med J 47, Suppl. 87, 1971
  • Levine, L. R. & McCain, E.: Cefamandole in the treatment of infections due to enterobacter and indole-positive proteus. J Infect Dis 137, Suppl. 125, 1978
  • Levine, L. R. & McCain, E.: Clinical experience with cefamandole for treatment of serious bone and joint infections. J Infect Dis 137, Suppl. 119, 1978
  • Levine, L. R., Russell, D. G. & McCain, E.: Cefamandole in the treatment of anaerobic infections. Contemp Surg 13:33, 1978
  • Lunke, R.J., Fitzgerald, R. H. Jr, Washingtron, J. A. II & Kelly, P. J.: Interstitial fluid pharmacokinetics of cefamandole in canine bone, Eighteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, October 1–4, 1978. (Abstract 234.)
  • Meyers, B. R., Shear, K., Wormser, G., Gartenberg, G., Nicholas, P. & Hirschman, S. Z.: Cefamandole therapy in seriously ill hospitalized patients. In: Current chemotherapy, p. 258 (ed. W. Siegenthaler and R. Luthy). American Society for Microbiology, Washington, D.C. 1978
  • Minor, M. R., Sande, M. A., Dilworth, J. A. & Mandell, G. L.: Cefamandole treatment of pulmonary infection caused by gram-negative rods. J Antimicrob Chemother 2:49, 1976
  • Neu, H. C.: Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother 6: 177, 1974
  • Parry, M. F., Garvey, G. J., Goldberger, M. J. & Neu, H. C.: Treatment of serious infections with cefamandole. In: Current chemotherapy, p. 262 (ed. W. Siegenthaler and R. Luthy). American Society for Microbiology, Washington, D.C. 1978
  • Perkins, R. L., Fass, R. J., Warner, J. F., Prior, R. B., File, T. M., Tight, R. R., Gardner, W. G., Ruiz, D. E. & Slama, T. G.: Cefamandole nafate therapy of respiratory tract, skin and soft tissue infections in 74 patients. J Infect Dis 137, Suppl. 110, 1978
  • Perlino, C. A. & Plaut, M. E.: Cefamandole treatment of bacterial pneumonia. Curr Ther Res 22:807, 1977
  • Petty, B., Smith, C., Wade, J., Conrad, G., Lipsky, J. & Ellner/Leitman, P.: Double-blind comparison of cefamandole and penicillin in pneumococcal pneumonia. Antimicrob Agents Chemother 14: 13, 1978
  • Plaut, M. E. & Perlino, C. A.: Cefamandole vs. procaine penicillin for treatment of pneumonia due to streptococcus pneumoniae: A random trial. J Infect Dis 137, Suppl. 133, 1978
  • Quinn, E. L., Madhavan, T., Wixson, R., Guise, E., Levin, N., Block, M., Burch, K., Fisher, E., Suarez, A. & del Busto, R.: Cefamandole: Observations on its spectrum, concentration in bone and bile, excretion in renal failure, and clinical efficacy. In: Current chemotherapy, p. 803 (ed. W. Siegenthaler and R. Luthy). American Society for Microbiology, Washington, D.C. 1978
  • Schurman, D. J., Moser, K., Hirshman, H. & Burton, D.: Cephalotin and cefamandole penetration into bone, synovial and drainage fluid, in press.
  • Short, H. D., Gentry, L. O. & Sessoms, S.: Cefamandole nafate therapy in the treatment of acute urinary tract infections. J Antimicrob Chemother 2: 345, 1976
  • Stone, H. H., Guest, B. S., Geheber, C. E. & Kolb, L. D.: Cefamandole in treatment of peritonitis. J Infect Dis 137, Suppl. 103, 1978
  • Stone, H. H., Morris, E. S., Kolb, L. D., Geheber, C. E. & Jackson, J. D.: Clinical comparison of cefamandole versus gentamicin in the treatment of peritonitis. Clin Pharmacol Ther 25: 251, 1979
  • Waldvogel, F. A., Medoff, G. & Swartz, M. N.: Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. I. N Engl J Med 282:198, 1970
  • Wick, W. E. & Preston, D. A.: Biological properties of 3-heterocyclic-thiomethyl cephalosporin antibiotics. Antimicrob Agents Chemother 1:221, 1972

References

  • McCabe, W. R. & Jackson, G. G.: Gram-negative bacteremia. I. Etiology and ecology. Arch Int Med 110:847, 1962
  • Kleeman, C. R., Hewitt, W. L. & Guze, L. B.: Pyelonephritis. Medicine 39: 3, 1960
  • Appel, G. B. & Neu, H. C.: The nephrotoxicity of antimicrobial agents. N Engl J Med 296:663, 1977
  • Fillastre, J. P., Laumonier, R., Humbert, G., Dubois, D., Metayer, J., Delpect, A., Leroy, J. & Robert, M.: Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J 2: 396, 1968
  • Klastersky, J., Henri, A., Hensgens, C. & Daneau, D.: Gram-negative infections in cancer study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin. JAMA 227:45, 1974
  • Kleinknecht, D., Ganeval, D. & Droz, D.: Acute renal failure after high doses of gentamicin and cephalothin. Lancet 1: 1129, 1973
  • The EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Inf Dis 137: 14, 1978
  • Gentry, L. O.: Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections. J Inf Dis 137( Suppl.) S144, 1978
  • Walker, B. D. & Gentry, L. O.: A randomized comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections. J Infect Dis 134( Suppl.) S146, 1976
  • Madsen, P. O., Kjaer, T. B. & Mosegaurd, A.: Comparison of tobramycin and gentamicin in the treatment of complicated urinary tract infections. J Infect Dis 134( Suppl.) S150, 1976
  • Gilbert, D. N., Plamp, C., Starr, P., Bennett, W. M. Houghton, D. C. & Porter, G.: Comparative nephrotoxicity of gentamicin and tobramycin in rats. Antimicrob Agents Chemother 13: 34, 1978
  • Alfthan, O., Renkonen, O. V. & Sivonen, A.: Concentration of gentamicin in serum urine and urogenital tissue in man. Acta Path Microbiol Scand Section B 81, Suppl. 241:92, 1973
  • Siebert, W. T., Westerman, E. L., Smilack, J. D., Bradshaw, M. M. & Williams, T. W., Jr: Comparison of thrombophlebitis associated with three cephalosporin antibiotics. Antimicrob Agents Chemother 10: 467, 1976

References

  • Barrett-Connor, E.: The non-value of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Resp Dis 103:845, 1971
  • Barza, M.: The nephrotoxicity of cephalosporins: An overview. J Infect Dis 137:51, 1978
  • Meyers, B. R., Leng, B. & Hirschman, S. Z.: Cefamandole: Antimicrobial activity in vitro of a new cephalosporin. J Antimicrob Chemother 8:734, 1975
  • Neu, H. C.: Cefamandole, cephalosporin antibiotics with an unusually wide spectrum of activity. J Antimicrob Chemother 6: 177, 1974
  • Neu, H. C.: Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis 139:80, 1978

References

  • Bauer, A. W., Kirby, W. M. M., Sherris, J. C. & Turck, M.: Antibiotic susceptibility testing by a standardized single disc method. Amer J Clin Path 45:493, 1966
  • Delgado, D. G., Brau, C. J., Cobbs, C. G. & Dismukes, W. E.: Clinical and laboratory evaluation of cefamandole in the therapy of Haemophilus spp. bronchopulmonary infections. Antimicrob Agents Chemother 15:807, 1979
  • Eickhoff, T. C. & Ehret, J. M.: In vitro comparison of cefoxitin, cefamandole, cephalexin, cephalothin. Antimicrob Agents Chemother 9:994, 1976
  • Everett, E. D., Rahm, A. E., Adaniya, R. Stevens, D. L. & McNitt, T. R.: Haemophilus influenzae pneumonia in adults. JAMA 238:319, 1977
  • Finland, M., Garner, C., Wilcox, C. & Sabath, L. D.: Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrob Agents Chemother 9:274, 1976
  • Hirschmann, J. V. & Everett, E. D.: Haemophilus influenzae infections in adults: Report of nine cases and a review of the literature. Medicine 58:80, 1979
  • Johnson, W. D., Kaye, D. & Hook, E. W.: Hemophilus influenzae pneumonia in adults. Report of five cases and review of the literature. Amer Rev Resp Dis 97: 1112, 1968
  • Jorgensen, J. H. & Alexander, G. A.: Comparative activities of selected Beta-lactam antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother 13:342, 1978
  • Levin, D. C., Schwarz, M. I., Matthay, R. A. & La-Force, F. M.: Bacteremic hemophilus influenzae pneumonia in adults. A report of 24 cases and a review of the literature. Amer J Med 62:219, 1977
  • Minor, M. R., Sande, M. A., Dilworth, J. A. & Mandell, G. L.: Cefamandole treatment of pulmonary infection caused by gram-negative rods. J Antimicrob Chemother 2:49, 1976
  • Morbidity and mortality. Bacterial meningitis and meningococcemia-United States, 1978. MNWR 28: no. 24, June 22, 1979
  • Perlino, C. A. & Plaut, M. E.: Cefamandole treatment of bacterial pneumonia. Curr Ther Res 22:807, 1977
  • Petty, B. G., Smith, C. R., Wade, J. C., Conrad, G. L., Lipsky, J. J., Ellner, J. J. & Leitman, P. S.: Double-blind comparison of cefamandole and penicillin in pneumococcal pneumonia. Antimicrob Agents Chemother 14:13, 1978
  • Rodriquez, W. J., Ross, S., Khan, W. N. & Goldenberg, R.: Clinical and laboratory evaluation of cefamandole in infants and children. J Infect Dis 137S: S150, 1978
  • Schwartz, R., Rodriquez, W. J., Khan, W. N. & Ross, S.: The increasing incidence of ampicillin-resistant Haemophilus influenzae. JAMA 239:320, 1978
  • Sosna, J., Murray, P. & Medoff, G.: Comparison of the in vitro activity of HR756 with other cephalosporins. 18th ICAAC, no. 78, American Society for Microbiology, 1978
  • Wallace, R. J., Musher, D. M. & Martin, R. R.: Hemophilus influenzae pneumonia in adults. Amer J Med 64:87, 1978

References

  • Burke, J. F.: Preventive antibiotics in surgery. In: Infections of prosthetic heart valves and vascular grafts (ed. R. J. Duma), chapter 14, pp. 305–312. University Park Press, Baltimore
  • Goodman, J. S., Schaufner, W., Collins, H. A., Batterby, E. J. & Koenig, M. G.: Infection after cardio vascular surgery; clinical study including examination of antimicrobial prophylaxis. N Engl J Med 278: 117–123, 1968
  • Fekety, F. R., Cluff, L. E., Sabiston, D. C., Seidl, L. G., Smith, J. W. & Thoburn, R.: A study of antibiotic prophylaxis in cardiac surgery. J Thorac Cardiovasc Surg 57:757–763, 1969

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.